Fair Value of Financial Instruments (Tables)

3 Months Ended

Dec. 31, 2018

The following table presents assets and liabilities measured and recorded at fair value on our balance sheets on a recurring basis (in thousands):


	December 31, 2018								September 30, 2018
	Level 1		Level 2		Level 3		Total		Level 1		Level 2		Level 3		Total
Assets
Cash equivalents	$	—	$	—	$	—	$	—	$	9,000	$	—	$	—	$	9,000
Current derivative assets		—		5,036		—		5,036		—		1,803		—		1,803
Noncurrent derivative assets		—		581		—		581		—		314		—		314
Total assets measured at fair value	$	—	$	5,617	$	—	$	5,617	$	9,000	$	2,117	$	—	$	11,117
Liabilities
Current derivative liabilities		—		3,367		—		3,367		—		1,657		—		1,657
Noncurrent derivative liabilities		—		—		—		—		—		75		—		75
Contingent consideration to seller of Deltenna		—		—		1,343		1,343		—		—		1,081		1,081
Contingent consideration to seller of Shield		—		—		5,618		5,618		—		—		5,618		5,618
Contingent consideration to seller of TeraLogics - revenue targets		—		—		—		—		—		—		1,750		1,750
Contingent consideration to seller of H4 Global		—		—		832		832		—		—		665		665
Total liabilities measured at fair value	$	—	$	3,367	$	7,793	$	11,160	$	—	$	1,732	$	9,114	$	10,846

As of December 31, 2018, the following table summarizes the change in fair value of our Level 3 contingent consideration liabilities (in thousands):


		H4 Global		TeraLogics (Revenue Targets)		Deltenna		Shield		Total
Net balances at September 30, 2018	$	665	$	1,750	$	1,081	$	5,618	$	9,114
Cash paid to seller		—		(1,750)		—		—		(1,750)
Total remeasurement (gain) loss recognized in earnings		167		—		262		—		429
Balance as of December 31, 2018	$	832	$	—	$	1,343	$	5,618	$	7,793

The following table presents the estimated fair value and carrying value of our long-term debt (in millions):